Many people with fatty liver disease wonder whether everyday beverage choices, including sparkling water, might worsen their condition. Fatty liver disease, now termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects approximately one in three UK adults and is closely linked to dietary factors—particularly sugar intake. Whilst sugar-sweetened fizzy drinks are known contributors to liver fat accumulation, plain sparkling water is fundamentally different. This article examines the evidence on carbonated water and liver health, clarifies common misconceptions, and provides practical guidance on optimal hydration choices for managing fatty liver disease.

Understanding Fatty Liver Disease and Dietary Factors

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells—specifically, when fat is present in 5% or more of hepatocytes (liver cells). The condition exists in two primary forms: metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), which affects individuals who drink little to no alcohol, and alcohol-related liver disease (ARLD). MASLD has become increasingly prevalent in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.

The liver plays a crucial role in metabolising nutrients, filtering waste products, and regulating blood sugar levels. When fat accumulates beyond normal levels, simple steatosis can progress to metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), potentially leading to fibrosis, cirrhosis, or liver failure if left unmanaged. Early-stage fatty liver disease typically presents no symptoms, making it a silent condition often discovered incidentally during routine blood tests or imaging. It is important to note that liver blood tests (liver enzymes) can be entirely normal in people with MASLD, so diagnosis often relies on imaging or risk-based assessment in primary care.

Dietary factors significantly influence fatty liver development and progression. The primary dietary culprits include excessive consumption of refined carbohydrates, added sugars (particularly fructose), saturated fats, and overall caloric excess. Sugar-sweetened beverages have been particularly implicated in MASLD development, as fructose metabolism in the liver promotes de novo lipogenesis—the conversion of sugars into fat. Conversely, dietary patterns emphasising whole foods, lean proteins, healthy fats, and adequate hydration support liver health.

Understanding which beverages and foods genuinely impact liver health versus those that are neutral or beneficial is essential for patients managing or preventing fatty liver disease. This knowledge empowers informed dietary choices that align with evidence-based recommendations from organisations such as NICE, the British Liver Trust, and the NHS.

Is Sparkling Water Bad for Fatty Liver?

There is no evidence that plain sparkling water (carbonated water) is harmful to individuals with fatty liver disease. Sparkling water is simply water infused with carbon dioxide gas under pressure, creating carbonic acid that produces the characteristic fizz and slightly acidic taste. This process does not add sugars, calories, artificial sweeteners, or other compounds that would negatively impact liver metabolism.

The confusion surrounding sparkling water and liver health likely stems from conflating plain carbonated water with sugar-sweetened carbonated beverages such as soft drinks and fizzy drinks. These sugar-laden beverages contain high amounts of fructose or glucose, which directly contribute to hepatic fat accumulation through increased lipogenesis and insulin resistance. Research published in hepatology journals consistently demonstrates that regular consumption of sugar-sweetened beverages significantly increases MASLD risk and severity.

Plain sparkling water, whether naturally carbonated mineral water or artificially carbonated tap water, contains zero calories and no added sugars. From a liver health perspective, there is no evidence that carbonation itself influences liver fat content, inflammatory markers, or hepatic enzyme levels. UK guidance from NICE, the NHS, and the British Liver Trust does not advise against plain carbonated water for people with fatty liver disease.

Some individuals may experience mild gastrointestinal effects from carbonated beverages, including bloating or increased gastric distension, but these are digestive rather than hepatic concerns. For patients with fatty liver disease seeking to maintain adequate hydration whilst reducing sugar intake, plain sparkling water represents a perfectly acceptable alternative to still water.

One consideration: Some mineral waters can be high in sodium (salt). If your clinician has advised you to restrict salt intake—for example, due to high blood pressure, fluid retention, or advanced liver disease—check the label and choose low-sodium varieties or still water.

Carbonated Water vs Sugary Drinks: What the Evidence Shows

The scientific literature draws a clear distinction between plain carbonated water and sugar-sweetened carbonated beverages regarding liver health outcomes. Systematic reviews examining dietary factors in MASLD have found that sugar-sweetened beverage consumption is independently associated with increased liver fat content, elevated liver enzymes, and greater MASLD severity, even after adjusting for total caloric intake and body mass index. The mechanism involves fructose metabolism, which bypasses key regulatory steps in glycolysis, leading directly to hepatic lipogenesis and triglyceride accumulation.

Studies examining water consumption (still or sparkling) have found no adverse metabolic effects on liver health. Research demonstrates that replacing sugar-sweetened beverages with plain water—whether still or sparkling—reduces sugar and energy intake and can support weight management and improve metabolic parameters, both beneficial for fatty liver disease. Reducing overall sugar intake, particularly from beverages, is a cornerstone of dietary management for MASLD.

The critical differentiator is the presence or absence of added sugars and calories. A standard 330 ml can of cola contains approximately 35 g of sugar (equivalent to seven teaspoons) and 139 calories, whereas the same volume of plain sparkling water contains zero of both. This distinction has profound implications for hepatic metabolism. The liver must process the substantial fructose load from sugary drinks, promoting fat synthesis, whereas sparkling water requires no such metabolic processing.

Patients should also be aware of flavoured sparkling waters, which vary considerably in composition. Some contain only natural flavourings without added sugars or sweeteners, remaining calorie-free and acceptable for liver health. Others include fruit juice concentrates or added sugars, which contribute to caloric intake and should be limited. Sugar-free flavoured waters containing non-nutritive (artificial) sweeteners are not currently contraindicated by UK guidance for people with MASLD, though evidence on long-term metabolic effects continues to evolve. Reading ingredient labels carefully helps distinguish truly sugar-free options from those that may contribute to sugar or calorie intake.

Best Hydration Choices for Liver Health

Adequate hydration supports optimal liver function and overall health by maintaining blood volume, supporting kidney function, enabling nutrient transport, and facilitating normal metabolic processes. For individuals with fatty liver disease, the best beverage choices include plain water (still or sparkling), unsweetened tea, and black coffee. These options provide hydration without adding sugars, excessive calories, or compounds that burden hepatic metabolism.

Plain water remains the gold standard for hydration. Whether still or sparkling, water supports liver health by maintaining circulation and supporting the kidneys in clearing metabolic waste products. The NHS recommends consuming 6–8 glasses (approximately 1.2–1.6 litres) of fluid daily, though individual requirements vary based on body size, activity level, and climate. If you have been advised to restrict salt, check the sodium content of mineral waters and choose low-sodium varieties.

Unsweetened tea, particularly green tea, offers additional benefits beyond hydration. Research suggests that green tea catechins, especially epigallocatechin gallate (EGCG), may possess hepatoprotective properties, potentially reducing liver fat accumulation and inflammation. A meta-analysis of clinical trials found that green tea consumption was associated with modest reductions in liver enzyme levels in people with MASLD. Black tea and herbal teas (without added sugars) also provide calorie-free hydration options. Important note: Brewed green tea at normal intakes is generally safe; however, high-dose green tea extract supplements have been associated with liver injury and should be used with caution. If you experience suspected side effects from any medicine, vaccine, or herbal supplement, report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Coffee consumption has been observationally associated with reduced MASLD progression risk. Multiple epidemiological studies demonstrate that regular coffee intake correlates with lower rates of liver fibrosis and cirrhosis. The mechanisms likely involve caffeine and polyphenolic compounds that may reduce hepatic inflammation and fibrosis. Liver societies, including the European Association for the Study of the Liver (EASL), note this association in their guidance, though coffee is not formally recommended as a therapeutic intervention.

Beverages to limit or avoid include:

• Sugar-sweetened drinks (soft drinks, fruit juices, energy drinks, sweetened teas and coffees)

• Alcohol, which directly causes hepatic steatosis and inflammation; UK Chief Medical Officers advise no more than 14 units per week, spread over 3 or more days, with several alcohol-free days

• Excessive fruit juice, even 100% juice, due to high fructose content and lack of fibre

• Beverages with added sugars or high-calorie content

Patients should prioritise water-based hydration whilst incorporating unsweetened tea or coffee according to personal preference, creating sustainable hydration habits that support long-term liver health.

When to Seek Medical Advice About Fatty Liver

Fatty liver disease often remains asymptomatic in early stages, making proactive medical engagement essential for at-risk individuals. You should consult your GP if you have risk factors for MASLD, including obesity (BMI ≥30 kg/m²), type 2 diabetes, metabolic syndrome, high cholesterol, or a family history of liver disease. Routine blood tests may reveal elevated liver enzymes (ALT, AST, GGT), prompting further investigation. However, it is important to know that liver enzymes can be entirely normal in people with MASLD, so risk-based assessment is important even when blood tests appear reassuring.

Seek medical attention if you experience symptoms potentially indicating advanced liver disease:

• Persistent fatigue or weakness

• Unexplained weight loss

• Abdominal pain or discomfort, particularly in the upper right quadrant

• Jaundice (yellowing of skin or eyes)

• Dark urine or pale stools

• Easy bruising or bleeding

• Swelling in the legs or abdomen (oedema or ascites)

• Confusion or difficulty concentrating (potential hepatic encephalopathy)

NICE guidelines (NG49) recommend that patients with confirmed MASLD undergo regular monitoring and assessment of fibrosis risk. In primary care, your GP will typically use a non-invasive scoring system such as the FIB-4 index (which uses age, liver enzymes, and platelet count) or the NAFLD fibrosis score as a first step. If your score is above the lower cut-off, indicating possible fibrosis, your GP may arrange an Enhanced Liver Fibrosis (ELF) blood test or refer you for transient elastography (FibroScan), a specialised ultrasound that measures liver stiffness. If results suggest significant fibrosis or if you have additional liver disease risk factors, your GP will refer you to a hepatologist (liver specialist). For adults with low-risk MASLD, repeat non-invasive testing is typically recommended approximately every three years.

Lifestyle modification remains the cornerstone of MASLD management. Evidence-based interventions include achieving 7–10% body weight reduction through caloric restriction and increased physical activity, following a Mediterranean-style dietary pattern, limiting alcohol consumption, and managing associated metabolic conditions such as diabetes and high cholesterol. Your GP can provide referrals to dietitians, weight management programmes, or diabetes services as appropriate.

Regular follow-up allows monitoring of disease progression and assessment of intervention effectiveness. Early detection and management of fatty liver disease can prevent progression to more serious conditions, making timely medical consultation crucial for anyone with risk factors or concerning symptoms.

Frequently Asked Questions